InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: JRoon71 post# 405249

Wednesday, 03/08/2023 9:49:40 AM

Wednesday, March 08, 2023 9:49:40 AM

Post# of 425648
j, forget about further indications as there is no large FDA-approved trial going on investigating V. MITIGATE and BRAVE do not count as they are too small.
The ONLY way out is for Denner to find a BP which would find Vascepa to be synergistic with its existing cardiovascular portfolio.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News